BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PrimeraDx Featured in the Goldman, Sachs & Co. Healthcare Research Team's GS Emerging Healthcare Series


5/10/2013 9:35:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MANSFIELD, Mass., May 9, 2013 /PRNewswire/ -- PrimeraDx, Inc., a molecular diagnostics company, will be highlighted in a conference call with the Goldman Sachs Healthcare Research Team as part of the GS Emerging Healthcare Series on May 13, 2013 at 11 am. Matthew McManus, MD, Ph.D., President and CEO of PrimeraDx will provide an overview of the Company's innovative technology and its two-pronged approach to the market: offering an "open platform" system to reference labs, academic medical centers and large hospital systems and also partnering with pharmaceutical companies to develop cutting-edge companion diagnostic products. Isaac Ro, Goldman Sachs Life Science Tools & Diagnostics Analyst will host the call.

Dial in information: 877-208-2954 or 973-528-0056
Conference Entry Code: 938134
Webcast: http://www.visualwebcaster.com/event.asp?id=94044

Replay information
Access #: 800.332.6854 OR 973.528.0005
Conference Entry Code: 938134
Dates: 5/13 5/27 (2 weeks)

About PrimeraDx
PrimeraDx is a molecular diagnostics company marketing an innovative clinical platform which combines PCR with capillary electrophoresis for multiplexed, information-rich molecular diagnostics used in Oncology, Infectious Disease, and Genetic Testing. The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed, multi-modal, and quantitative answers to the clinic. Users can easily design very complex assays that simultaneously test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes. PrimeraDx's technology represents the next generation of quantitative, multiplex PCR. The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysian Technology Development Corporation. The Company's website is: www.primeradx.com.

CONTACT: Ted Myles, CFO, (508) 618-2300

SOURCE PrimeraDx, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES